Reinnervate and Tecan Sign Co-marketing Agreement

News   Nov 27, 2012

 
Reinnervate and Tecan Sign Co-marketing Agreement
 
 
 

RELATED ARTICLES

IDEX Health & Science Announces Acquisition of New Microfluidics Company

News

IDEX Health & Science, LLC announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business.

READ MORE

Agent Reverses Resistance to Targeted Drug in Some Leukemias

News

After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent.

READ MORE

New Drug Delivery System Targets Diseases at a Genetic Level

News

A new drug delivery system that uses a synthetic-biological hybrid nanocapsule could provide a smart technology for targeted treatment of a variety of serious diseases at the genetic level.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE